ASRT vs DD · rev $125.0M vs P/E 127, rev $12.39B
Assertio Therapeutics Inc (ASRT) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
ASRT currently screens at market cap $151.5M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the ASRT and DD stock pages for the full models.
Not investment advice.